Side-by-side comparison of AI visibility scores, market position, and capabilities
Colgate-Palmolive (NYSE: CL) #1 global toothpaste brand at $20.1B company revenue with 1-in-3 global brushers; competing with P&G Oral-B and Sensodyne across 200+ countries for oral care leadership.
Colgate is the flagship oral care brand of Colgate-Palmolive Company (NYSE: CL) — a New York-based global consumer products company founded in 1806 — producing toothpaste, toothbrushes, mouthwash, whitening products, and children's oral care across 200+ countries and territories with an estimated $10+ billion in annual brand revenue. Colgate-Palmolive generated $20.1 billion in total revenue in fiscal year 2024 across Oral Care, Personal Care, Home Care, and Pet Nutrition (Hill's Science Diet). Colgate holds the #1 global toothpaste market share position — the Colgate brand is used by approximately 1 in 3 people who brush their teeth globally — with particularly dominant positions in emerging markets (India, Latin America, Africa) where Colgate's brand recognition exceeds 90% in many markets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.